贝达喹啉导致的舒张功能障碍:病例报告

Ireen C. Bwalya
{"title":"贝达喹啉导致的舒张功能障碍:病例报告","authors":"Ireen C. Bwalya","doi":"10.55320/mjz.50.3.412","DOIUrl":null,"url":null,"abstract":"Abstract \nBackground \nThere is no published case of diastolic dysfunction arising due to bedaquiline treatment for Multi-Drug Resistant Tuberculosis (MDR-TB). Diastolic dysfunction is not listed as a potential complication of treatment with bedaquiline. This case report is the first to link bedaquiline to diastolic dysfunction. Clinicians should be aware of this potential complication, and ensure that patients are monitored and investigated appropriately. \nCase Presentation \nA 47 year old female presented with fever, productive cough and drenching night sweats for more than 2 weeks prior to presentation. There was no hemoptysis, chest pains or weight loss. She however, felt breathless after a heavy bout of coughing.  Fever was intermittent, and most pronounced at night. The patient denied any weight loss over the past month. The patient had no history of HIV, diabetes, hypertension or  heart disease. There were no previous episodes of TB. There was history of contact with a patient with MDR-TB patient. The patients’ son, who shared a house and all living spaces with the patient, was being treated for MDR-TB at the time of presentation. The patient did not drink or smoke. There was no history of illicit drug use. She worked as a restaurant manager.  Due to the history of very close contact with MDR-TB, the patient was commenced on the longer, oral only regimen for MDR-TB which includes bedaquiline. Four weeks after commencement of bedaquiline, the patient complained that both feet were swelling.  There were no other symptoms or signs of cardiovascular disease. An Echocardiogram done during the fifth month showed an ejection fraction of 71% and diastolic dysfunction. The patient was commenced on diuretics and continued on MDR-TB treatment. An echocardiogram that was repeated at month 15 review showed an ejection fraction of 64%, normal left ventricle and normal systolic and diastolic function. \nConclusions \nDiastolic Dysfunction has not previously been reported in patients on bedaquiline. This is the first case report to link bedaquiline to diastolic dysfunction. More studies need to be done to determine conclusively whether bedaquiline can cause diastolic dysfunction.","PeriodicalId":74149,"journal":{"name":"Medical journal of Zambia","volume":"43 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diastolic dysfunction due to bedaquiline: A case report\",\"authors\":\"Ireen C. Bwalya\",\"doi\":\"10.55320/mjz.50.3.412\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract \\nBackground \\nThere is no published case of diastolic dysfunction arising due to bedaquiline treatment for Multi-Drug Resistant Tuberculosis (MDR-TB). Diastolic dysfunction is not listed as a potential complication of treatment with bedaquiline. This case report is the first to link bedaquiline to diastolic dysfunction. Clinicians should be aware of this potential complication, and ensure that patients are monitored and investigated appropriately. \\nCase Presentation \\nA 47 year old female presented with fever, productive cough and drenching night sweats for more than 2 weeks prior to presentation. There was no hemoptysis, chest pains or weight loss. She however, felt breathless after a heavy bout of coughing.  Fever was intermittent, and most pronounced at night. The patient denied any weight loss over the past month. The patient had no history of HIV, diabetes, hypertension or  heart disease. There were no previous episodes of TB. There was history of contact with a patient with MDR-TB patient. The patients’ son, who shared a house and all living spaces with the patient, was being treated for MDR-TB at the time of presentation. The patient did not drink or smoke. There was no history of illicit drug use. She worked as a restaurant manager.  Due to the history of very close contact with MDR-TB, the patient was commenced on the longer, oral only regimen for MDR-TB which includes bedaquiline. Four weeks after commencement of bedaquiline, the patient complained that both feet were swelling.  There were no other symptoms or signs of cardiovascular disease. An Echocardiogram done during the fifth month showed an ejection fraction of 71% and diastolic dysfunction. The patient was commenced on diuretics and continued on MDR-TB treatment. An echocardiogram that was repeated at month 15 review showed an ejection fraction of 64%, normal left ventricle and normal systolic and diastolic function. \\nConclusions \\nDiastolic Dysfunction has not previously been reported in patients on bedaquiline. This is the first case report to link bedaquiline to diastolic dysfunction. More studies need to be done to determine conclusively whether bedaquiline can cause diastolic dysfunction.\",\"PeriodicalId\":74149,\"journal\":{\"name\":\"Medical journal of Zambia\",\"volume\":\"43 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical journal of Zambia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55320/mjz.50.3.412\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical journal of Zambia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55320/mjz.50.3.412","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

摘要 背景 目前还没有关于贝达喹啉治疗耐多药结核病(MDR-TB)导致舒张功能障碍的公开病例。舒张功能障碍未被列为贝达喹啉治疗的潜在并发症。本病例报告首次将贝达喹啉与舒张功能障碍联系起来。临床医生应了解这一潜在并发症,并确保对患者进行适当的监测和检查。病例介绍 一位 47 岁的女性患者在发病前 2 周多出现发热、有痰咳嗽和盗汗。她没有咯血、胸痛或体重减轻。然而,她在一阵剧烈咳嗽后感到呼吸困难。 发热呈间歇性,夜间最为明显。患者否认过去一个月体重下降。患者没有艾滋病、糖尿病、高血压或心脏病史。既往没有结核病史。曾与一名 MDR-TB 患者有过接触史。患者的儿子与患者同住一栋房屋和所有生活空间,发病时正在接受 MDR-TB 治疗。患者不喝酒也不吸烟。没有非法吸毒史。她的工作是餐厅经理。 由于曾与 MDR-TB 病例有非常密切的接触史,患者开始接受较长时间的 MDR-TB 口服治疗,其中包括贝达喹啉。开始服用贝达喹啉四周后,患者抱怨双脚肿胀。 患者没有其他心血管疾病的症状或体征。第五个月进行的超声心动图检查显示,射血分数为71%,舒张功能障碍。患者开始服用利尿剂,并继续接受耐多药结核病治疗。第 15 个月复查时,超声心动图显示射血分数为 64%,左心室正常,收缩和舒张功能正常。结论 以前从未有服用贝达喹啉的患者出现舒张功能障碍的报道。这是首例将贝达喹啉与舒张功能障碍联系起来的病例报告。要最终确定贝达喹啉是否会导致舒张功能障碍,还需要进行更多的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Diastolic dysfunction due to bedaquiline: A case report
Abstract Background There is no published case of diastolic dysfunction arising due to bedaquiline treatment for Multi-Drug Resistant Tuberculosis (MDR-TB). Diastolic dysfunction is not listed as a potential complication of treatment with bedaquiline. This case report is the first to link bedaquiline to diastolic dysfunction. Clinicians should be aware of this potential complication, and ensure that patients are monitored and investigated appropriately. Case Presentation A 47 year old female presented with fever, productive cough and drenching night sweats for more than 2 weeks prior to presentation. There was no hemoptysis, chest pains or weight loss. She however, felt breathless after a heavy bout of coughing.  Fever was intermittent, and most pronounced at night. The patient denied any weight loss over the past month. The patient had no history of HIV, diabetes, hypertension or  heart disease. There were no previous episodes of TB. There was history of contact with a patient with MDR-TB patient. The patients’ son, who shared a house and all living spaces with the patient, was being treated for MDR-TB at the time of presentation. The patient did not drink or smoke. There was no history of illicit drug use. She worked as a restaurant manager.  Due to the history of very close contact with MDR-TB, the patient was commenced on the longer, oral only regimen for MDR-TB which includes bedaquiline. Four weeks after commencement of bedaquiline, the patient complained that both feet were swelling.  There were no other symptoms or signs of cardiovascular disease. An Echocardiogram done during the fifth month showed an ejection fraction of 71% and diastolic dysfunction. The patient was commenced on diuretics and continued on MDR-TB treatment. An echocardiogram that was repeated at month 15 review showed an ejection fraction of 64%, normal left ventricle and normal systolic and diastolic function. Conclusions Diastolic Dysfunction has not previously been reported in patients on bedaquiline. This is the first case report to link bedaquiline to diastolic dysfunction. More studies need to be done to determine conclusively whether bedaquiline can cause diastolic dysfunction.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Workplace experiences of diagnostic radiographers, on job satisfaction and staff retention in the public health sector in Lusaka District of Zambia Role Development and Extension for Radiographers in Computed Tomography: Literature Review Findings and their Application to Zimbabwe Role of Radiographers in the Provision of Diagnostic Medical Ultrasound Services in Zimbabwe: Past, Present and Way Forward Lipoprotein (a) as a cause of premature coronary artery disease; a case report of a 34-year-old male patient presenting with ST elevation myocardial infarction. Gastrointestinal malignancies in Zambia: a scoping review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1